2025-05-05 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Report

**0) Executive Summary:**

UnitedHealth Group Inc. (UNH), a diversified healthcare company, shows a cumulative return significantly lagging the S&P 500 (VOO) over the analyzed period. While exhibiting strong revenue and profitability, recent performance indicates a period of underperformance relative to the broader market.  Further analysis is needed to determine whether this underperformance presents a buying opportunity.

**1) Performance Comparison:**

* **Company Overview:** UnitedHealth Group Inc. is a leading diversified healthcare company offering a broad spectrum of health benefits programs and healthcare services.

* **Cumulative Returns:**
    * UNH: 42.19%
    * VOO (S&P 500): 82.57%
    * **Return Difference:** UNH underperformed VOO by 40.38 percentage points.  This places UNH at the 3rd percentile of its historical performance range relative to the S&P 500 (-40.4 out of a range between -43.3 and 53.4).

* **Alpha and Beta Analysis:** The provided data shows fluctuating alpha (outperformance relative to the market) and beta (market sensitivity) values across the years.  While alpha is generally positive, indicating some degree of outperformance, it's inconsistent,  and  beta suggests significant market sensitivity. The considerable variation in CAGR (Compound Annual Growth Rate) and MDD (Maximum Drawdown) highlights the volatility of UNH's performance.  Market capitalization (Cap(B)) shows substantial growth over the period.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 67.0% | 55.4% | 35.0% | 0.1 | 180.1 |
| 2016-2018  | 59.0% | 63.7% | 38.0% | 0.2 | 206.3 |
| 2017-2019  | 45.0% | 63.7% | 11.0% | 0.4 | 247.6 |
| 2018-2020  | -17.0% | 63.7% | -47.0% | 0.6 | 300.2 |
| 2019-2021  | 39.0% | 61.0% | -22.0% | 0.7 | 435.9 |
| 2020-2022  | 32.0% | 66.9% | 24.0% | 0.7 | 466.1 |
| 2021-2023  | 39.0% | 67.8% | 18.0% | 0.4 | 469.8 |
| 2022-2024  | -27.0% | 69.0% | -47.0% | 0.3 | 458.5 |
| 2023-2025  | -44.0% | 75.2% | -65.0% | 0.2 | 386.2 |


**2) Recent Price Movement:**

* **Closing Price:** $424.25
* **Last Market:** {'price': 399.92, 'previousClose': 400.68, 'change': -0.19}  (Slight decrease)
* **5-Day Moving Average:** $431.77
* **20-Day Moving Average:** $521.60
* **60-Day Moving Average:** $509.30

The price is below all three moving averages, suggesting a potential downtrend.  The recent price drop is minimal and may not be significant on its own.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4053 (Medium Risk)
* **RSI:** 28.79 (Suggests oversold conditions, potentially indicating a bounce back, but this is not a guarantee).
* **PPO:** -3.57 (Negative value suggests bearish momentum).
* **20-Day Relative Strength Change:** -53.5% (Significant recent underperformance relative to the market).
* **Expected Return:** 410% (This figure requires further context and clarification.  It's unclear how this 410% figure is derived or what assumptions it relies upon).


The combination of low RSI, negative PPO, and significant negative relative strength indicates a bearish trend, at least short term.  The slight price drop in the "Last Market" data doesn't suggest a significant event (no sudden crash or rapid rebound).  The expected return of 410% needs further explanation and justification.


**4) Recent Earnings Analysis:**

The earnings data shows inconsistent EPS, with a significant negative EPS in 2024-05-09.  Revenue remains relatively stable and high.  Further analysis is needed to understand the cause of the negative EPS and the overall trend.  There is duplicate data for 2024-11-04.

| Date       | EPS   | Revenue       |
|------------|-------|---------------|
| 2024-11-04 | 6.56  | 100.82 B$     |
| 2024-08-09 | 4.58  | 98.86 B$      |
| 2024-05-09 | -1.53 | 99.80 B$      |
| 2023-11-06 | 6.31  | 92.36 B$      |
| 2024-11-04 | 6.31  | 92.36 B$      | *(Duplicate Data)*


**5) Financial Information:**

Both Revenue and Profitability show generally strong performance with high and relatively stable revenue figures.  Profit margins also remain consistently high, hovering around 22%. Equity and Return on Equity (ROE) fluctuate, with a negative ROE in Q1 2024. This requires further investigation to identify the underlying reasons.

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $100.81B  | 21.14%        |
| 2024-09-30 | $100.82B  | 22.84%        |
| 2024-06-30 | $98.86B   | 22.31%        |
| 2024-03-31 | $99.80B   | 23.05%        |
| 2023-12-31 | $94.43B   | 23.30%        |

**Capital and Profitability:**

| Quarter | Equity     | ROE   |
|---------|-------------|-------|
| 2024-12-31 | $92.66B   | 5.98% |
| 2024-09-30 | $94.53B   | 6.41% |
| 2024-06-30 | $89.36B   | 4.72% |
| 2024-03-31 | $86.69B   | -1.63% |
| 2023-12-31 | $88.76B   | 6.15% |


**6) Overall Analysis:**

UNH shows strong fundamental metrics in terms of revenue and profitability. However, its recent performance lags the S&P 500 significantly. Technical indicators suggest a bearish trend in the short term. The inconsistent EPS and fluctuating ROE require further investigation.  The provided "expected return" of 410% needs more detail.  A deeper dive into the reasons for the underperformance relative to the market, the negative EPS in Q2 2024, and the variability in ROE is crucial before forming a definitive investment opinion.  Consider consulting financial statements and conducting further due diligence before making any investment decisions.
